Renee Lb Pederson, RPH , CDM Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2694 N County Rd #1100 E, Lerna, IL 62440 Phone: 217-345-7846 |
News Archive
In four separate pivotal clinical studies presented on Friday, a greater percentage of moderate to severe chronic plaque psoriasis patients treated with briakinumab, Abbott's investigational IL-12/23 inhibitor (ABT-874), achieved 75 percent or better skin clearance rates than those treated with etanercept (EnbrelĀ®), methotrexate or placebo. Abbott presented data from all briakinumab pivotal studies in psoriasis at the European Association of Dermatology and Venereology scientific sessions.
Universal Capital Management, Inc. (OTCBB: UCMT), a Wilmington, Delaware business development company that provides management and strategic growth resources to emerging growth companies, is pleased to announce the addition of Innovation Industries to its portfolio.
Although the "foreign affairs legacy of President Bush so far speaks most loudly of terrorism, Afghanistan and the quagmire in Iraq," statistics released recently by the Organization for Economic Co-operation and Development indicate the Bush - "partly under pressure from his Christian supporters" and celebrities - has "dramatically increased U.S. aid to Africa," columnist David Usborne writes.
A new study, presented today at the AATS 101st Annual Meeting, found that severely ill COVID-19 patients treated with ECMO did not suffer worse long-term outcomes than other mechanically-ventilated patients.
Thirty-four percent of malaria-endemic countries are complying with WHO guidelines to monitor artemisinin resistance within their borders, the agency said in a report on Thursday, CBS News reports (11/18). Reuters reports that artemisinin "is the best drug available against malaria, especially when used in artemisinin combination therapy (ACT), which combines it with other drugs that finish off the [malaria] parasite" (Nebehay, 11/18).
› Verified 9 days ago